Arsenic Trioxide Injection, Solution
FDA Label NDC 49315-007

1 label section · Submitted to the FDA by Zydus Lifesciences Limited · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Zydus Lifesciences Limited for the product Arsenic Trioxide (NDC 49315-007). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding package label.principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Package Label.Principal Display Panel

PRINCIPAL DISPLAY PANEL - Vial Label

NDC 49315-007-01

Arsenic Trioxide Injection

12 mg/6 mL

(2 mg/mL)

NEW CONCENTRATION

For Intravenous Use Only

Cytotoxic Agent

6 mL Single-Dose Vial

Rx only

Zydus Pharmaceuticals

Vial Label (2e2ef17f 6d1c 43ab B764 6b659da79cd2 02)

Vial Label (2e2ef17f 6d1c 43ab B764 6b659da79cd2 02)

PRINCIPAL DISPLAY PANEL - Carton Label

NDC 49315-007-10

Arsenic Trioxide Injection

12 mg/6 mL

(2 mg/mL)

NEW CONCENTRATION

For Intravenous Use Only

10 X 6 mL Single-Dose Vials

Rx only

Zydus Pharmaceuticals

Carton Label (2e2ef17f 6d1c 43ab B764 6b659da79cd2 03)

Carton Label (2e2ef17f 6d1c 43ab B764 6b659da79cd2 03)

* Please review the disclaimer below.